Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: Results from a multicenter observational longitudinal study in China

Neurological Research

Volumn 30, Issue 4, 2008, Pages 370-376

  Zheng, Huaguang ^a   Liu, Liping ^a   Sun, Haixin ^a   Wang, Xianwei ^a   Wang, Yilong ^a   Zhou, Yong ^a   Lu, Jingjing ^a   Zhao, Xingquan ^a   Wang, Chunxue ^a   Dong, Kehui ^a   Yang, Zhonghua ^a   Wang, Yongjun ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Acute stroke guideline; Coagulation; Deep venous thrombosis; Prophylaxis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL PRACTICE; CONFIDENCE INTERVAL; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PROPHYLAXIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE PATIENT; VARICOSIS; VEIN CATHETERIZATION;

AGED; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; CHINA; CLINICAL PROTOCOLS; COMORBIDITY; DATABASES, FACTUAL; DIABETES COMPLICATIONS; FEMALE; GUIDELINE ADHERENCE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VARICOSE VEINS; VENOUS THROMBOSIS;

EID: 45849150010     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313208X300387     Document Type: Article

References (19)

1. He J, Gu DF, Wu XG, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124-1134
2. Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke. Stroke 2001; 32: 262-267
3. Adams HP, Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711
4. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38: 2001-2023
5. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132: 936-945
6. Amin A, Stemkowski S, Lin J, et al. Thromboprophylaxis rates in US medical centers: Success or failure? J Thromb Haemost 2007; 5: 1610-1616
7. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007; 119: 145-155
8. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): An open-label randomized comparision. Lancet 2007; 369: 1347-1355
9. Diener HC, Ringelstein EB, von Kummer R, et al. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: Results of the PROTECT Trial. Stroke 2006; 37: 139-144
10. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800
11. Leizorovicz A, Cohen AT, Turpie G, et al. Randomized, placebo controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879
12. Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-288
13. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res 2007; 119: 265-274
14. Geerts WH, Pineo GF, Heit JA, et al. The Seventh ACCP Conference on Prevention of Venous Thromboembolism: Antithrombotic and thrombolytic therapy. Chest 2004; 126: 338-400
15. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: A consensus statement from the Brain Attack Coalition. Stroke 2005; 36: 1597-1616
16. Francis CW. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 2007; 356: 1438-1444
17. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: Prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007; 132: 554-561
18. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005; 241: 397-415
19. Sellier E, Labarere J, Bosson JL, et al. Effectiveness of a guideline for venousthromboembolism prophylaxisin elderly post-acute care patients: A multicenter study with systematic ultrasonographic examination. Arch Intern Med 2006; 166: 2065-2071